Cargando…

Altered Gut Microbiota in Patients With Peutz–Jeghers Syndrome

BACKGROUND: Peutz–Jeghers syndrome (PJS) is a rare genetic disorder characterized by the development of pigmented spots and gastrointestinal polyps and increased susceptibility to cancers. It remains unknown whether gut microbiota dysbiosis is linked to PJS. AIM: This study aimed to assess the struc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Sui, Huang, Gang, Wang, Jue-Xin, Tian, Lin, Zuo, Xiu-Li, Li, Yan-Qing, Yu, Yan-Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326469/
https://www.ncbi.nlm.nih.gov/pubmed/35910641
http://dx.doi.org/10.3389/fmicb.2022.881508
_version_ 1784757293278035968
author Wang, Sui
Huang, Gang
Wang, Jue-Xin
Tian, Lin
Zuo, Xiu-Li
Li, Yan-Qing
Yu, Yan-Bo
author_facet Wang, Sui
Huang, Gang
Wang, Jue-Xin
Tian, Lin
Zuo, Xiu-Li
Li, Yan-Qing
Yu, Yan-Bo
author_sort Wang, Sui
collection PubMed
description BACKGROUND: Peutz–Jeghers syndrome (PJS) is a rare genetic disorder characterized by the development of pigmented spots and gastrointestinal polyps and increased susceptibility to cancers. It remains unknown whether gut microbiota dysbiosis is linked to PJS. AIM: This study aimed to assess the structure and composition of the gut microbiota, including both bacteria and fungi, in patients with PJS and investigate the relationship between gut microbiota dysbiosis and PJS pathogenesis. METHODS: The bacterial and fungal composition of the fecal microbiota was analyzed in 23 patients with PJS (cases), 17 first-degree asymptomatic relatives (ARs), and 24 healthy controls (HCs) using 16S (MiSeq) and ITS2 (pyrosequencing) sequencing for bacteria and fungi, respectively. Differential analyses of the intestinal flora were performed from the phylum to species level. RESULTS: Alpha-diversity distributions of bacteria and fungi indicated that the abundance of both taxa differed between PJS cases and controls. However, while the diversity and composition of fecal bacteria in PJS cases were significantly different from those in ARs and HCs, fungal flora was more stable. High-throughput sequencing confirmed the special characteristics and biodiversity of the fecal bacterial and fungal microflora in patients with PJS. They had lower bacterial biodiversity than controls, with a higher frequency of the Proteobacteria phylum, Enterobacteriaceae family, and Escherichia-Shigella genus, and a lower frequency of the Firmicutes phylum and the Lachnospiraceae and Ruminococcaceae families. Of fungi, Candida was significantly higher in PJS cases than in controls. CONCLUSION: The findings reported here confirm gut microbiota dysbiosis in patients with PJS. This is the first report on the bacterial and fungal microbiota profile of subjects with PJS, which may be meaningful to provide a structural basis for further research on intestinal microecology in PJS.
format Online
Article
Text
id pubmed-9326469
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93264692022-07-28 Altered Gut Microbiota in Patients With Peutz–Jeghers Syndrome Wang, Sui Huang, Gang Wang, Jue-Xin Tian, Lin Zuo, Xiu-Li Li, Yan-Qing Yu, Yan-Bo Front Microbiol Microbiology BACKGROUND: Peutz–Jeghers syndrome (PJS) is a rare genetic disorder characterized by the development of pigmented spots and gastrointestinal polyps and increased susceptibility to cancers. It remains unknown whether gut microbiota dysbiosis is linked to PJS. AIM: This study aimed to assess the structure and composition of the gut microbiota, including both bacteria and fungi, in patients with PJS and investigate the relationship between gut microbiota dysbiosis and PJS pathogenesis. METHODS: The bacterial and fungal composition of the fecal microbiota was analyzed in 23 patients with PJS (cases), 17 first-degree asymptomatic relatives (ARs), and 24 healthy controls (HCs) using 16S (MiSeq) and ITS2 (pyrosequencing) sequencing for bacteria and fungi, respectively. Differential analyses of the intestinal flora were performed from the phylum to species level. RESULTS: Alpha-diversity distributions of bacteria and fungi indicated that the abundance of both taxa differed between PJS cases and controls. However, while the diversity and composition of fecal bacteria in PJS cases were significantly different from those in ARs and HCs, fungal flora was more stable. High-throughput sequencing confirmed the special characteristics and biodiversity of the fecal bacterial and fungal microflora in patients with PJS. They had lower bacterial biodiversity than controls, with a higher frequency of the Proteobacteria phylum, Enterobacteriaceae family, and Escherichia-Shigella genus, and a lower frequency of the Firmicutes phylum and the Lachnospiraceae and Ruminococcaceae families. Of fungi, Candida was significantly higher in PJS cases than in controls. CONCLUSION: The findings reported here confirm gut microbiota dysbiosis in patients with PJS. This is the first report on the bacterial and fungal microbiota profile of subjects with PJS, which may be meaningful to provide a structural basis for further research on intestinal microecology in PJS. Frontiers Media S.A. 2022-07-13 /pmc/articles/PMC9326469/ /pubmed/35910641 http://dx.doi.org/10.3389/fmicb.2022.881508 Text en Copyright © 2022 Wang, Huang, Wang, Tian, Zuo, Li and Yu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Wang, Sui
Huang, Gang
Wang, Jue-Xin
Tian, Lin
Zuo, Xiu-Li
Li, Yan-Qing
Yu, Yan-Bo
Altered Gut Microbiota in Patients With Peutz–Jeghers Syndrome
title Altered Gut Microbiota in Patients With Peutz–Jeghers Syndrome
title_full Altered Gut Microbiota in Patients With Peutz–Jeghers Syndrome
title_fullStr Altered Gut Microbiota in Patients With Peutz–Jeghers Syndrome
title_full_unstemmed Altered Gut Microbiota in Patients With Peutz–Jeghers Syndrome
title_short Altered Gut Microbiota in Patients With Peutz–Jeghers Syndrome
title_sort altered gut microbiota in patients with peutz–jeghers syndrome
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326469/
https://www.ncbi.nlm.nih.gov/pubmed/35910641
http://dx.doi.org/10.3389/fmicb.2022.881508
work_keys_str_mv AT wangsui alteredgutmicrobiotainpatientswithpeutzjegherssyndrome
AT huanggang alteredgutmicrobiotainpatientswithpeutzjegherssyndrome
AT wangjuexin alteredgutmicrobiotainpatientswithpeutzjegherssyndrome
AT tianlin alteredgutmicrobiotainpatientswithpeutzjegherssyndrome
AT zuoxiuli alteredgutmicrobiotainpatientswithpeutzjegherssyndrome
AT liyanqing alteredgutmicrobiotainpatientswithpeutzjegherssyndrome
AT yuyanbo alteredgutmicrobiotainpatientswithpeutzjegherssyndrome